Carles Monterrubio
Overview
Explore the profile of Carles Monterrubio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balaguer-Lluna L, Olaciregui N, Aschero R, Resa-Pares C, Paco S, Cuadrado-Vilanova M, et al.
J Neurooncol
. 2025 Feb;
PMID: 39961939
Purpose: We aimed to expand and refine the experimental models for pediatric-type diffuse high grade gliomas (pHGG) and the methods to follow up disease progression in mouse pHGG xenografts. Methods:...
2.
Aschero R, Castillo-Ecija H, Baulenas-Farres M, Resa-Pares C, Jimenez-Cabaco A, Rodriguez E, et al.
Pediatr Blood Cancer
. 2023 Mar;
70(6):e30318.
PMID: 36973999
Background: Successful engraftment of human cancer biopsies in immunodeficient mice correlates with the poor prognosis of patients. This was reported 30 years ago for children with neuroblastoma, but the standard...
3.
Castillo-Ecija H, Pascual-Pasto G, Perez-Jaume S, Resa-Pares C, Vila-Ubach M, Monterrubio C, et al.
J Pathol Clin Res
. 2021 Apr;
7(4):338-349.
PMID: 33837665
The goals of this work were to identify factors favoring patient-derived xenograft (PDX) engraftment and study the association between PDX engraftment and prognosis in pediatric patients with Ewing sarcoma, osteosarcoma,...
4.
Castillo-Ecija H, Monterrubio C, Pascual-Pasto G, Gomez-Gonzalez S, Garcia-Dominguez D, Hontecillas-Prieto L, et al.
J Control Release
. 2020 Jun;
324:440-449.
PMID: 32497782
Ewing sarcoma is a bone and soft tissue tumor predominantly affecting adolescents and young adults. To characterize changes in anticancer drug activity and intratumor drug distribution during the evolution of...
5.
Manzanares A, Restrepo-Perdomo C, Botteri G, Castillo-Ecija H, Pascual-Pasto G, Cano F, et al.
Adv Healthc Mater
. 2018 Jun;
7(15):e1800255.
PMID: 29892999
Delivery of chemotherapy in the surgical bed has shown preclinical activity to control cancer progression upon subtotal resection of pediatric solid tumors, but whether this new treatment is safe for...
6.
Bukchin A, Pascual-Pasto G, Cuadrado-Vilanova M, Castillo-Ecija H, Monterrubio C, Olaciregui N, et al.
J Control Release
. 2018 Mar;
276:59-71.
PMID: 29501533
We report for the first time on a nano-drug delivery system based on glucosylated polymeric nanomicelles to actively target the second-generation tyrosine kinase inhibitor dasatinib to glucose-avid pediatric sarcomas by...
7.
Floros K, Lochmann T, Hu B, Monterrubio C, Hughes M, Wells J, et al.
Proc Natl Acad Sci U S A
. 2018 Feb;
115(11):E2594-E2603.
PMID: 29476008
() amplification is a driving oncogenic event in breast cancer. Clinical trials have consistently shown the benefit of HER2 inhibitors (HER2i) in treating patients with both local and advanced HER2+...
8.
Monterrubio C, Paco S, Olaciregui N, Pascual-Pasto G, Vila-Ubach M, Cuadrado-Vilanova M, et al.
J Control Release
. 2017 Apr;
255:108-119.
PMID: 28412222
Neuroblastoma is a pediatric solid tumor with high expression of the tumor associated antigen disialoganglioside GD2. Despite initial response to induction therapy, nearly 50% of high-risk neuroblastomas recur because of...
9.
Pascual-Pasto G, Olaciregui N, Vila-Ubach M, Paco S, Monterrubio C, Rodriguez E, et al.
Cancer Lett
. 2016 Jun;
380(1):10-9.
PMID: 27319373
Translational research in retinoblastoma - a pediatric tumor that originates during the development of the retina - would be improved by the creation of new patient-derived models. Using tumor samples...
10.
Monterrubio C, Pascual-Pasto G, Cano F, Vila-Ubach M, Manzanares A, Schaiquevich P, et al.
Biomaterials
. 2015 Dec;
79:69-78.
PMID: 26695118
In addition to surgery, local tumor control in pediatric oncology requires new treatments as an alternative to radiotherapy. SN-38 is an anticancer drug with proved activity against several pediatric solid...